|
MRPL15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.421200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.201900E-04 |
| Normal-vs-Stage2 |
3.632200E-01 |
| Normal-vs-Stage3 |
7.067800E-01 |
| Normal-vs-Stage4 |
4.930800E-01 |
| Stage1-vs-Stage2 |
4.163000E-01 |
| Stage1-vs-Stage3 |
8.310300E-02 |
| Stage1-vs-Stage4 |
4.527900E-02 |
| Stage2-vs-Stage3 |
5.517800E-01 |
| Stage2-vs-Stage4 |
2.494200E-01 |
| Stage3-vs-Stage4 |
3.518000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.210000E-04 |
| Normal-vs-AfricanAmerican |
3.276400E-02 |
| Normal-vs-Asian |
9.899800E-01 |
| Caucasian-vs-AfricanAmerican |
6.435200E-01 |
| Caucasian-vs-Asian |
5.725400E-01 |
| AfricanAmerican-vs-Asian |
4.506800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.400500E-04 |
| Normal-vs-Female |
4.448000E-02 |
| Male-vs-Female |
2.656000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.504000E-02 |
| Normal-vs-Extreme_Weight |
2.147700E-02 |
| Normal-vs-Obese |
2.175700E-02 |
| Normal-vs-Extreme_Obese |
8.685000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.716200E-01 |
| Normal_Weight-vs-Obese |
8.771800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.524800E-01 |
| Extreme_Weight-vs-Obese |
9.886000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.735600E-01 |
| Obese-vs-Extreme_Obese |
5.869000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.221400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.185500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.058660E-03 |
| Normal-vs-Age(81-100Yrs) |
3.680200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.538000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.773000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.070400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.830800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.269200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.930600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.26540000000563E-06 |
| Normal-VS-Type2 PRCC |
2.770600E-01 |
| Normal-VS-KIRP CIMP |
7.877600E-01 |
| Normal-VS-Unclassified PRCC |
1.606150E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.679200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.752400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.672000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.507600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.350000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.769000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.268310E-02 |
| Normal-vs-N1 |
9.900600E-01 |
| Normal-vs-N2 |
4.584400E-03 |
| N0-vs-N1 |
9.561600E-02 |
| N0-vs-N2 |
3.963200E-01 |
| N1-vs-N2 |
1.434800E-01 |
|
|
